Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 2 of 2 for:    tofacitinib | Sarcoidosis

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03910543
Recruitment Status : Completed
First Posted : April 10, 2019
Last Update Posted : July 14, 2021
Information provided by (Responsible Party):
Yale University